ask="11.65"
ask_size="1000"
average_daily_volume="2132110"
bid="11.23"
bid_size="1000"
book_value="-0.09"
change="+0.32"
change_from_200_day_moving_average="0.70"
change_from_50_day_moving_average="0.23"
change_from_52_week_high="-2.83"
change_From_52_week_low="4.59"
change_in_percent="+2.85%"
close="11.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="94923000"
high="11.58"
high_52_weeks="14.38"
last_trade_date="1/31/2017"
last_trade_price="11.55"
last_trade_size="103264"
last_trade_time="4:00pm"
low="10.89"
low_52_weeks="6.96"
market_capitalization="1.48B"
moving_average_200_day="10.85"
moving_average_50_day="11.32"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="11.13"
pe_ratio="N/A"
peg_ratio="-0.23"
percent_change_from_200_day_moving_average="+6.41%"
percent_change_from_50_day_moving_average="+2.04%"
percent_change_from_52_week_high="-19.68%"
percent_change_from_52_week_low="+65.95%"
previous_close="11.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.00"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="9.08"
stock_exchange="NMS"
symbol="HALO"
volume="1800286"
weeks_range_52="6.96 - 14.38"
